Wealth Enhancement Advisory Services LLC Has $2.78 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wealth Enhancement Advisory Services LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 33.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 248,672 shares of the pharmacy operator's stock after acquiring an additional 61,838 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Walgreens Boots Alliance were worth $2,778,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Central Pacific Bank Trust Division raised its position in Walgreens Boots Alliance by 28.6% during the first quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock valued at $50,000 after acquiring an additional 1,000 shares in the last quarter. Metis Global Partners LLC increased its stake in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after purchasing an additional 1,118 shares during the last quarter. Harbour Investments Inc. raised its holdings in shares of Walgreens Boots Alliance by 4.3% during the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after purchasing an additional 1,165 shares in the last quarter. Unison Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 2.8% in the 4th quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock valued at $403,000 after purchasing an additional 1,168 shares during the last quarter. Finally, Avantax Advisory Services Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.4% in the 4th quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock valued at $466,000 after purchasing an additional 1,186 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA traded up $0.01 during trading on Tuesday, hitting $11.49. The company's stock had a trading volume of 7,409,666 shares, compared to its average volume of 19,863,936. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. The firm has a 50 day moving average price of $11.23 and a 200 day moving average price of $10.85. The firm has a market cap of $9.95 billion, a P/E ratio of -1.58, a price-to-earnings-growth ratio of 1.36 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The company had revenue of $38.99 billion during the quarter, compared to analysts' expectations of $36.72 billion. During the same period in the prior year, the business earned $0.63 earnings per share. Walgreens Boots Alliance's revenue for the quarter was up 7.2% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

WBA has been the topic of several recent research reports. Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, UBS Group restated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $10.59.

Insider Transactions at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina acquired 832,258 shares of the business's stock in a transaction dated Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman owned 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 17.50% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.